Literature DB >> 26063755

The value of models in informing resource allocation in colorectal cancer screening: the case of The Netherlands.

Frank van Hees1, Ann G Zauber2, Harriët van Veldhuizen3, Marie-Louise A Heijnen4, Corine Penning1, Harry J de Koning1, Marjolein van Ballegooijen1, Iris Lansdorp-Vogelaar1.   

Abstract

In May 2011, the Dutch government decided to implement a national programme for colorectal cancer (CRC) screening using biennial faecal immunochemical test screening between ages 55 and 75. Decision modelling played an important role in informing this decision, as well as in the planning and implementation of the programme afterwards. In this overview, we illustrate the value of models in informing resource allocation in CRC screening using the role that decision modelling has played in the Dutch CRC screening programme as an example. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  COLORECTAL CANCER SCREENING; COST-EFFECTIVENESS

Mesh：

Year:  2015        PMID： 26063755      PMCID： PMC4672636          DOI： 10.1136/gutjnl-2015-309316

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  46 in total

1.  Polyps of the colon in Barcelona, Spain. An autopsy study.

Authors:  J A Bombi
Journal:  Cancer       Date:  1988-04-01       Impact factor: 6.860

2.  Extra incidence caused by mammographic screening.

Authors:  R Boer; P Warmerdam; H de Koning; G van Oortmarssen
Journal:  Lancet       Date:  1994-04-16       Impact factor: 79.321

3.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

4.  The evolution of cancer of the colon and rectum.

Authors:  T Muto; H J Bussey; B C Morson
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

5.  Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer.

Authors:  J C Clark; Y Collan; T J Eide; J Estève; S Ewen; N M Gibbs; O M Jensen; E Koskela; R MacLennan; J G Simpson
Journal:  Int J Cancer       Date:  1985-08-15       Impact factor: 7.396

6.  Polyps and cancer of the large bowel: a necropsy study in Liverpool.

Authors:  A R Williams; B A Balasooriya; D W Day
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

7.  Potential impact of population-based colorectal cancer screening in Canada.

Authors:  William M Flanagan; Christel Le Petit; Jean-Marie Berthelot; Kathleen J White; B Ann Coombs; Elaine Jones-McLean
Journal:  Chronic Dis Can       Date:  2003

8.  Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand.

Authors:  J R Jass; P J Young; E M Robinson
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

9.  The prevalence of polyps of the large intestine in Oslo: an autopsy study.

Authors:  M H Vatn; H Stalsberg
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

10.  Polyps of the large intestine in Aarhus, Denmark. An autopsy study.

Authors:  L G Johannsen; O Momsen; N O Jacobsen
Journal:  Scand J Gastroenterol       Date:  1989-09       Impact factor: 2.423
View more
  26 in total

1.  Screening Women Aged 50-59 for CRC Using Fecal Occult Blood Test Produces Outcomes Similar to Men Undergoing Screening Colonoscopy.

Authors:  Harrison M Mooers; Jennifer L Holub; David A Lieberman
Journal:  Dig Dis Sci       Date:  2018-06-13       Impact factor: 3.199

2.  The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics.

Authors:  Amanda F Petrik; Beverly B Green; William M Vollmer; Thuy Le; Barbara Bachman; Erin Keast; Jennifer Rivelli; Gloria D Coronado
Journal:  Fam Pract       Date:  2016-07-28       Impact factor: 2.267

3.  Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer.

Authors:  Reinier G S Meester; Chyke A Doubeni; Ann G Zauber; Marjolein van Ballegooijen; Douglas A Corley; Iris Lansdorp-Vogelaar
Journal:  Int J Cancer       Date:  2017-08-31       Impact factor: 7.396

4.  Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.

Authors:  Lucie de Jonge; Hilliene J van de Schootbrugge-Vandermeer; Emilie C H Breekveldt; Manon C W Spaander; Hanneke J van Vuuren; Folkert J van Kemenade; Evelien Dekker; Iris D Nagtegaal; Monique E van Leerdam; Iris Lansdorp-Vogelaar
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

5.  Cost-effectiveness analysis of colorectal cancer screening in Shanghai, China: A modelling study.

Authors:  Jie Wang; Lucie de Jonge; Dayna R Cenin; Pei Li; Sha Tao; Chen Yang; Bei Yan; Iris Lansdorp-Vogelaar
Journal:  Prev Med Rep       Date:  2022-07-04

6.  Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results.

Authors:  Maaike Buskermolen; Andrea Gini; Steffie K Naber; Esther Toes-Zoutendijk; Harry J de Koning; Iris Lansdorp-Vogelaar
Journal:  Med Decis Making       Date:  2018-10-20       Impact factor: 2.583

7.  Comparative benefit and cost-effectiveness of mailed-out faecal immunochemical tests vs collection at the general practitioner.

Authors:  Elisabeth F P Peterse; Caroline B Osoro; Marc Bardou; Iris Lansdorp-Vogelaar
Journal:  Aliment Pharmacol Ther       Date:  2021-03-08       Impact factor: 8.171

8.  Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program.

Authors:  Mercè Comas; Joan Mendivil; Montserrat Andreu; Cristina Hernández; Xavier Castells
Journal:  PLoS One       Date:  2016-10-12       Impact factor: 3.240

9.  Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test.

Authors:  Hermann Brenner; Simone Werner
Journal:  Clin Transl Gastroenterol       Date:  2017-08-03       Impact factor: 4.488

Review 10.  Colorectal cancer screening: the time to act is now.

Authors:  Hermann Brenner; Christian Stock; Michael Hoffmeister
Journal:  BMC Med       Date:  2015-10-13       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.